ArticleSurgical endoscopy2025
Robotic retromuscular hernia repair optimizes short-term outcomes in higher risk patients.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSmoking, obesity, diabetes mellitus, and COPD are known risk factors for surgical site occurrences (SSO) following open ventral hernia repair. However, little evidence exists on whether these factors also significantly impact SSO after robotic hernia repair. This is a particularly important distinction because robotic approaches have been associated with fewer wound complications. Our aim was to examine the impact of smoking, obesity, diabetes mellitus, and COPD on postoperative SSO after robotic retromuscular hernia repair.
methodsA retrospective review was conducted of a prospectively maintained database of ventral hernia repairs at three hospitals within our system from October 2019 to July 2022. These included extended totally extraperitoneal (eTEP) and transabdominal approaches along with transversus abdominis release (TAR). Patient demographics, preoperative evaluation, operative details, 30-day follow-up, and patient-reported outcomes were recorded in the Abdominal Core Health Quality Collaborative (ACHQC) database. Patients were grouped according to exposure; smokers vs. non-smokers, obesity (BMI > 40 vs. < 40), and the presence or absence of diabetes mellitus or COPD. The main outcome measure was SSO at one month follow-up. Logistic regression models were used to determine the association between smoking, obesity, diabetes mellitus, and COPD with postoperative SSO.
resultsA total of 81 adult patients were included; mean age was 55 ± 13 years and 41% were women. ASA scores were as follows: 1 (0%), 2 (30%), 3 (64%), and 4 (4%). The prevalence of risk factors were smoking 17%, obesity 16%, diabetes mellitus 28%, and COPD 6%. The overall SSO rate at 30-day follow-up was 12.2%. SSO rates for obese vs. non-obese patients were 15.4% vs. 11.5%, respectively (p = 0.7). For smokers, the rate of SSO compared to non-smokers was 11.1% vs. 13.3% (p = 0.5). Logistic regression models showed that obesity (OR 0.75, 95% CI 0.13, 4.31; p = 0.7), diabetes (OR 2.04, 95% CI 0.36, 11.7; p = 0.4), smoking (OR 2.55, 95% CI 0.27, 23.9; p = 0.4), and COPD (OR 0.32, 95% CI 0.03, 3.93; p = 0.4) were not predictive of postoperative SSO.
conclusionIn our study, smoking, obesity, diabetes mellitus, and COPD did not predict 30-day follow-up wound complications after robotic retromuscular hernia repair. Given these findings, patients who are unable to optimize these risk factors may still be offered robotic retromuscular repair without increasing risk of postoperative SSO.
Indexed as
Identifiers
40063143What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.